Deciphering transcriptomic determinants of the divergent link between PD-L1 and immunotherapy efficacy

Programmed cell death ligand 1 (PD-L1) expression remains the most widely used biomarker for predicting response to immune checkpoint inhibitors (ICI), but its predictiveness varies considerably. Identification of factors accounting for the varying PD-L1 performance is urgently needed. Here, using d...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Anlin, Luo, Linfeng, Du, Wei, Yu, Zhixin, He, Lina, Fu, Sha, Wang, Yuanyuan, Zhou, Yixin, Yang, Chunlong, Yang, Yunpeng, Fang, Wenfeng, Zhang, Li, Hong, Shaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495439/
https://www.ncbi.nlm.nih.gov/pubmed/37696887
http://dx.doi.org/10.1038/s41698-023-00443-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495439/
https://www.ncbi.nlm.nih.gov/pubmed/37696887
http://dx.doi.org/10.1038/s41698-023-00443-3

Ejemplares similares